Sickle cell vaso-occlusion: Multistep and multicellular paradigm

Current Opinion in Hematology

Volumn 9, Issue 2, 2002, Pages 101-106

  Frenette, Paul S ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD47 ANTIGEN; CELL ADHESION MOLECULE; FIBRONECTIN; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOGLOBIN S; LAMININ; PHOSPHATIDYLSERINE; SELECTIN; THROMBOSPONDIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

BLOOD VESSEL OCCLUSION; DISEASE SEVERITY; ERYTHROCYTE ADHESIVENESS; HUMAN; IN VIVO STUDY; INFLAMMATION; LEUKOCYTE ADHERENCE; LEUKOCYTOSIS; PRIORITY JOURNAL; REVIEW; SICKLE CELL ANEMIA; VASCULAR ENDOTHELIUM;

ANEMIA, SICKLE CELL; ENDOTHELIUM, VASCULAR; ERYTHROCYTE AGGREGATION; HUMANS; MICROCIRCULATION; MODELS, CARDIOVASCULAR; VASCULAR DISEASES;

EID: 0036177721     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-200203000-00003     Document Type: Review

References (51)

1. The emerging understanding of sickle cell disease
2. Adhesion of normal and sickle erythrocytes to endothelial monolayer cultures
3. Abnormal adherence of sickle erythrocytes to cultured vascular endothelium: Possible mechanism for microvascular occlusion in sickle cell disease
4. Erythrocyte adherence to endothelium in sickle-cell anemia: A possible determinant of disease severity
5. Sickle erythrocyte adherence to vascular endothelium: Morphologic correlates and the requirement for divalent cations and collagenbinding plasma proteins
6. Rheological studies of erythrocyte-endothelial cell interactions in sickle cell disease
7. Microvascular sites and characteristics of sickle cell adhesion to vascular endothelium in shear flow conditions: Pathophysiologic implications
8. Adherence of sickle erythrocytes to vascular endothelial cells: Requirement for both cell membrane changes and plasma factors
9. Fibrinogen, a modulator of erythrocyte adhesion to vascular endothelium
10. Thrombospondin mediates adherence of CD36+ sickle reticulocytes to endothelial cells
11. Glycoprotein IV-independent adhesion of sickle red blood cells to immobilized thrombospondin under flow conditions
12. Increased adhesion of erythrocytes to components of the extracellular matrix: Isolation and characterization of a red blood cell lipid that binds thrombospondin and laminin
13. Adherence of phosphatidylserine-exposing erythrocytes to endothelial matrix thrombospondin
14. Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin
15. Integrin-associated protein is an adhesion receptor on sickle red blood cells for immobilized thrombospondin
16. Basal cell adhesion molecule/Lutheran protein: The receptor critical for sickle cell adhesion to laminin
17. Lutheran blood group glycoprotein and its newly characterized mouse homologue specifically bind alpha5 chain-containing human laminin with high affinity
18. Alpha 4 beta 1-integrin expression on sickle reticulocytes: Vascular cell adhesion molecule-1-dependent binding to endothelium
19. Sickle reticulocytes adhere to VCAM-1
20. Monoclonal antibodies to alphaVbeta3 (7E3 and LM609) inhibit sickle red blood cell-endothelium interactions induced by platelet-activating factor
21. P-selectin mediates the adhesion of sickle erythrocytes to the endothelium
22. Spontaneous oxygen radical generation by sickle erythrocytes
23. Interaction of sickle erythrocytes with endothelial cells in the presence of endothelial cell conditioned medium induces oxidant stress leading to transendothelial migration of monocytes
24. Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase
25. Hypoxia/reoxygenation causes inflammatory response in transgenic sickle mice but not in normal mice
26. Activated monocytes in sickle cell disease: Potential role in the activation of vascular endothelium and vaso-occlusion
27. Elevated immunoreactive tumor necrosis factor and interleukin-1 in sickle cell disease
28. Levels of tumor necrosis factor alpha/cachectin (TNF alpha) in sera from patients with sickle cell disease
29. Circulating cytokines in sickle cell patients during steady state
30. Plasma endothelin-1, cytokine, and prostaglandin E2 levels in sickle cell disease and acute vaso-occlusive sickle crisis
31. Modulation of endothelial cell activation in sickle cell disease: A pilot study
32. Mortality in sickle cell disease: Life expectancy and risk factors for early death
33. Silent cerebral infarcts in sickle cell anemia: A risk factor analysis. The Cooperative Study of Sickle Cell Disease
34. Hydroxyurea and sickle cell anemia: Clinical utility of a myelosuppressive 'switching' agent, The Muiticenter Study of Hydroxyurea in Sickle Cell Anernia
35. Prediction of adverse outcomes in children with sickle cell disease
36. Sickle erythrocytes adhere to polymorphonuclear neutrophils and activate the neutrophil respiratory burst
37. Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease
38. Knockout-transgenic mouse model of sickle cell disease
39. Sickle cell interactions with adherent leukocytes can initiate venular occlusion in sickle cell mice
40. P- and E-selectin deficiency protects against tnf-alpha-induced venular occlusion in sickle mice: Evidence for a critical role for adherent leukocytes
41. Molgramostim to treat SS-sickle cell leg ulcers
42. Granulocytosis causing sickle-cell crisis
43. Fatal sickle cell crisis after granulocyte colony-stimulating factor administration
44. Granulocyte colony-stimulating factor-induced sickle cell crisis and multiorgan dysfunction in a patient with compound heterozygous sickle cell/beta+ thalassemia
45. Effects of in vivo administration of G-CSF on neutrophil and eosinophil adhesion
46. The morbidity of sickle cell trait: A review of the literature
47. Mobilization and apheresis of sickle cell trait donors is safe and feasible
48. Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity
49. Activation of sickle red blood cell adhesion via integrin-associated protein/CD47-induced signal transduction
50. Platelet-erythrocyte adhesion in sickle cell disease
51. Introduction: Anti-adhesion therapy in sickle cell disease